Moderna (MRNA) is a publicly traded Healthcare sector company. As of November 19, 2026, MRNA trades at $194.61 with a market cap of $83.68B and a P/E ratio of -23.88. MRNA moved -1.27% today. Year to date, MRNA is +511.57%; over the trailing twelve months it is +689.49%. Its 52-week range spans $22.28 to $280.80. Analyst consensus is neutral with an average price target of $145.38. Rallies surfaces MRNA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks MRNA insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $194.61 |
| Market Cap | $83.68B |
| P/E Ratio | -23.88 |
| EPS | $-7.98 |
| Dividend Yield | 0.00% |
| 52-Week High | $280.80 |
| 52-Week Low | $22.28 |
| Volume | 2.58M |
| Avg Volume | 0 |
| Revenue (TTM) | $2.23B |
| Net Income | $-3.15B |
| Gross Margin | 23.38% |
20 analysts cover MRNA: 0 strong buy, 2 buy, 15 hold, 3 sell, 0 strong sell. Consensus rating is neutral. Average price target: $145.38.